Your browser doesn't support javascript.
loading
HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.
Han, Tao; Chen, Tingsong; Chen, Lujun; Li, Kerui; Xiang, Daimin; Dou, Lei; Li, Hengyu; Gu, Yubei.
Afiliação
  • Han T; Department of Oncology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
  • Chen T; Department of Cancer Intervention, Seventh People's Hospital of Shanghai University of TCM, Shanghai, 200001, China.
  • Chen L; Department of Oncology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
  • Li K; Postgraduate College, China Medical University, Shenyang, 110001, China.
  • Xiang D; Department of Oncology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
  • Dou L; Clinical Cancer Institute, Center for Translational Medicine, Naval Military Medical University, Shanghai, 200433, China.
  • Li H; Department of hepatobiliary surgery, East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
  • Gu Y; Department of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China. doulei840416@163.com.
Cell Death Dis ; 14(9): 606, 2023 09 14.
Article em En | MEDLINE | ID: mdl-37709768
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article